🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Financial Toxicity in Patients With Early-stage Breast Cancer

Recruitingn/aAges any - anyAllNational Cancer Institute, Naples
NCT07354165 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Non-profit, multicenter, prospective, observational study. This study aims to evaluate whether the articulated treatment algorithm that is now possible for early-stage breast cancer patients does produce tangible changes of financial distress over the time and whether the determinants of financial distress change their relative weight over the time.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Signed informed consent form * Age \> 18 years at the time of study entry * Histologically confirmed stage I-III invasive breast carcinoma before starting any systemic treatment. Exclusion Criteria: * Stage IV invasive breast carcinoma * Major cognitive dysfunction or psychiatric disorders * Any previous systemic treatment for the current breast cancer
💊

What it tests

  • Questionnaires
📍

Where

1 site
National Cancer Institute of Napoli
Naples, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy